Stay updated on PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Marinesco-Sjögren syndrome and a Genetic and Rare Diseases Information Center resources entry to the page.
    Difference
    0.1%
    Check dated 2026-04-02T04:52:49.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0 and removal of v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:27:16.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T16:07:27.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1 banner.
    Difference
    0.4%
    Check dated 2026-02-11T02:35:57.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added a banner about government funding status and updated the page revision to v3.4.1, replacing the previous v3.4.0 revision note.
    Difference
    0.4%
    Check dated 2026-02-03T23:35:12.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page now includes a glossary control and updates several footer/metadata items, including Last Update Submitted that Met QC Criteria, Last Update Posted, capitalization changes to No FEAR Act Data, and the revision noted as v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:55:14.000Z thumbnail image

Stay in the know with updates to PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.